Expanding CAR-T Targets Beyond CD-19 to Enhance Treatment Efficacy Across Autoimmune Diseases
Time: 11:30 am
day: Conference Day One Pink Track P1
Details:
- Evaluate CD-19’s strengths and limitations as the anchor target for CAR-T treatment of autoimmune diseases
- Explore novel targets to broaden the spectrum and complexity of treatable autoimmune diseases
- Evaluate available targeting options to pinpoint optimal targets for varying autoimmune and autoinflammatory diseases
